COPENHAGEN —
Denmark has decided not to include Johnson
& Johnson's
COVID-19 shots in its vaccination program, several local media
reported on Monday citing unnamed sources.
اضافة اعلان
The Nordic country last month stopped using
AstraZeneca's vaccine altogether over a potential link to a rare but serious form of blood
clot.
Excluding the J&J vaccine, which accounts for around a
third of Denmark's total contracted supplies of COVID-19 shots, could
significantly delay the country's vaccination calendar.
The rollout of J&J's vaccine has also been delayed
elsewhere in Europe over similar clotting concerns.
Danish health authorities are expected to make an
announcement on the vaccine at the beginning of this week.
Europe's drug regulator, the European Medicines Agency, said
on April 20 it had found a possible link between J&J's vaccine and rare
blood clotting issues in adults who received doses in the United States.
But it backed the vaccine's overall benefits against any
risks.
EMA said its safety committee had concluded that a warning
about unusual blood clots with low platelets must be added to the vaccine's
labels, just as was required of AstraZeneca. J&J said in a news release
that it would comply with that measure.
Read more
region & world
.jpg)
.jpg)
